Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Retained Earnings (2018 - 2026)

Select Medical Holdings (SEM) has disclosed Retained Earnings for 9 consecutive years, with $872.2 million as the latest value for Q1 2026.

  • For Q1 2026, Retained Earnings rose 7.22% year-over-year to $872.2 million; the TTM value through Mar 2026 reached $872.2 million, up 7.22%, while the annual FY2025 figure was $837.0 million, 8.68% up from the prior year.
  • Retained Earnings hit $872.2 million in Q1 2026 for Select Medical Holdings, up from $837.0 million in the prior quarter.
  • Across five years, Retained Earnings topped out at $872.2 million in Q1 2026 and bottomed at -$5.2 million in Q2 2025.
  • Average Retained Earnings over 5 years is $484.0 million, with a median of $666.2 million recorded in 2023.
  • Year-over-year, Retained Earnings surged 4630.58% in 2022 and then tumbled 189.19% in 2025.
  • Select Medical Holdings' Retained Earnings stood at $581.0 million in 2022, then rose by 29.41% to $751.9 million in 2023, then increased by 2.43% to $770.1 million in 2024, then increased by 8.68% to $837.0 million in 2025, then rose by 4.21% to $872.2 million in 2026.
  • According to Business Quant data, Retained Earnings over the past three periods came in at $872.2 million, $837.0 million, and $824.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.